Skip to content
ppharmaranks
Menu
Class IIOngoing

Spironolactone Tablets recall

FDA recall D-0574-2025 · initiated Aug 5, 2025

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Aug 13, 2025How we research

SUN PHARMACEUTICAL INDUSTRIES INC recalled Spironolactone Tablets in Aug 2025 — an FDA Class II recall (D-0574-2025) because Presence of foreign substance: identified as aluminum.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Presence of foreign substance: identified as aluminum.

Something got into the product

A physical or chemical contaminant was found — glass or metal fragments, or a solvent that should not be there.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot # P3314, Exp 11/30/2026

Quantity recalled: 11,328 bottles

Details

Product
Spironolactone Tablets, USP, 25 mg, 100-count bottle, Rx only, Mfg. by: Frontida BioPharm, Inc., 1100 Orthodox St, Philadelphia, PA 19124, Dist. by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 53489-143-01
Recalling company
Sun Pharm Industries
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
USA Nationwide
Initiated
Aug 5, 2025
FDA report date
Aug 13, 2025
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Spironolactone Tablets recalled?
SUN PHARMACEUTICAL INDUSTRIES INC recalled Spironolactone Tablets in Aug 2025 — an FDA Class II recall (D-0574-2025) because Presence of foreign substance: identified as aluminum. May cause temporary or medically reversible harm; low probability of serious harm.
Why was Spironolactone Tablets recalled?
Per the FDA enforcement record, the reason for recall D-0574-2025 was: Presence of foreign substance: identified as aluminum.
Is a recalled Spironolactone Tablets dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Spironolactone Tablets are affected?
Distributed: USA Nationwide. The recall covers these lots — Lot # P3314, Exp 11/30/2026. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0574-2025.

Source: openFDA Drug Enforcement record D-0574-2025

← All drug recalls